{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:57:16Z","timestamp":1772143036708,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.disamonth.2012.01.009","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T19:15:39Z","timestamp":1332530139000},"page":"153-167","source":"Crossref","is-referenced-by-count":23,"title":["Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"58","author":[{"given":"Mohammed","family":"Shanshal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami Y.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.disamonth.2012.01.009_bib1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1517\/14656566.7.12.1641","article-title":"Fludarabine in chronic lymphocytic leukaemia","volume":"7","author":"Elter","year":"2006","journal-title":"Exp Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.disamonth.2012.01.009_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2012.01.009_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1097-0142(19950101)75:1+<381::AID-CNCR2820751320>3.0.CO;2-B","article-title":"Leukemias, myeloma, and other lymphoreticular neoplasms","volume":"75","author":"Hern\u00e1ndez","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.disamonth.2012.01.009_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.disamonth.2012.01.009_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0145-2126(03)00023-7","article-title":"Causation of chronic lymphocytic leukemia\u2014insights from familial disease","volume":"27","author":"Houlston","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.disamonth.2012.01.009_bib6","series-title":"Cancer Epidemiology and Prevention","first-page":"841","article-title":"The leukemias","author":"Linet","year":"2006"},{"issue":"6","key":"10.1016\/j.disamonth.2012.01.009_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2133.2004.05982.x","article-title":"Cutaneous findings in chronic lymphocytic leukaemia","volume":"150","author":"Agnew","year":"2004","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.disamonth.2012.01.009_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.1992.270","article-title":"Kidney glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas","volume":"42","author":"Moulin","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.disamonth.2012.01.009_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.009_bib10","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2012.01.009_bib11","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.4161\/cc.7.24.7245","article-title":"Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway","volume":"7","author":"Zenz","year":"2008","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.disamonth.2012.01.009_bib12","first-page":"679","article-title":"Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer","author":"Morris","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.disamonth.2012.01.009_bib14","first-page":"391","article-title":"Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies","volume":"90","author":"Montillo","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.disamonth.2012.01.009_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.009_bib16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.disamonth.2012.01.009_bib17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2007-05-092882","article-title":"Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia","volume":"112","author":"Rassenti","year":"2008","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.disamonth.2012.01.009_bib18","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2009-02-206185","article-title":"First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia","volume":"114","author":"Eichhorst","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2012.01.009_bib19","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1200\/JCO.2008.20.8389","article-title":"Phase III randomized study of Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia","volume":"27","author":"Knauf","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.disamonth.2012.01.009_bib20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/10428190601126636","article-title":"Immunomodulatory drugs in chronic lymphocytic leukemia: a new treatment paradigm","volume":"48","author":"Molica","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"17","key":"10.1016\/j.disamonth.2012.01.009_bib21","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/1078-0432.CCR-10-0570","article-title":"U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab","volume":"16","author":"Lemery","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.disamonth.2012.01.009_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1200\/JCO.2009.25.3187","article-title":"Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia","volume":"28","author":"Wierda","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.009_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1749-6632.2009.04803.x","article-title":"Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement\/rituximab interactions and clinical results in refractory CLL","volume":"1173","author":"Klepfish","year":"2009","journal-title":"Ann NY Acad Sci"},{"issue":"10","key":"10.1016\/j.disamonth.2012.01.009_bib24","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1200\/JCO.2009.26.4556","article-title":"Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia","volume":"28","author":"Robak","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.disamonth.2012.01.009_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2009-08-237727","article-title":"Chronic lymphocytic leukemia cyclophosphamide, and rituximab in patients with relapsed or refractory phase 1\/2 study of lumiliximab combined with fludarabine","volume":"115","author":"Byrd","year":"2010","journal-title":"Blood J"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502912000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502912000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:26:37Z","timestamp":1593887197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502912000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0011502912000107"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2012.01.009","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}